Impact of 13-valent pneumococcal conjugate vaccine on the incidence of hospitalizations for all-cause pneumonia among children aged less than 5 years in Burkina Faso: An interrupted time-series analysis

Impact of 13-valent pneumococcal conjugate vaccine on the incidence of hospitalizations for all-cause pneumonia among children aged less than 5 years in Burkina Faso: An interrupted time-series analysis

Background: Pneumococcal disease is a major public health concern globally and particularly in Burkina Faso, where the 13-valent pneumococcal conjugate vaccine (PCV13) was introduced nationwide into the routine immunization schedule in 2013. The aim of this study was to evaluate vaccine impact on al...

Full description

Bibliographic Details
Main Authors: Lassané Kaboré, Seydou Ouattara, François Sawadogo, Alain Gervaix, Annick Galetto-Lacour, Robert Karama, Amado T. Traoré, Bertrand Méda, Haoua Tall, Alima T. Essoh, Bradford D. Gessner, Jennifer C. Moïsi
Format: Article
Language:English
Published: Elsevier 2020-07-01
Series:International Journal of Infectious Diseases
Subjects:
PCV13
Impact
Pneumonia
Children
Burkina Faso
Online Access:http://www.sciencedirect.com/science/article/pii/S1201971220301831

Internet

http://www.sciencedirect.com/science/article/pii/S1201971220301831

Similar Items